is reporting from
PROSTATE CANCER RESEARCH
JonBaker | March 11, 2008 at 10:09 amby
284 views | 0 Recommendations | 1 comment
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA (prostate specific antigen) , a potential diagnostic indicator of prostate cancer.